Observed therapy started in Baltimore.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015142:Baltimore; D006679:HIV Seropositivity / Q000188:drug therapy*; D006801:Humans; D010349:Patient Compliance
D019380:Anti-HIV Agents